NCT00143845View on ClinicalTrials.gov

Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

November 30, 2010

Study Completion Date

February 28, 2013

Conditions
Multiple MyelomaLymphocytic Leukemia, ChronicLymphoma, Low-Grade
Interventions
PROCEDURE

Reduced intensity conditioning

Busulfan and Fludarabine regimen

PROCEDURE

Rapid immunosuppressive taper

Taper of Tacrolimus, Methotrexate and Mycophenolate Mofetil

PROCEDURE

Prophylactic donor leukocyte infusions

If the patient has GVHD overall grade 0-1 or skin grade 1 on day +100, then 5 x 107 CD3+ cells/kg recipient weight are given.

Trial Locations (1)

48109

The University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT00143845 - Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant | Biotech Hunter | Biotech Hunter